Corcept Therapeutics Incorporated (CORT) has a consensus analyst rating of Buy, based on 25 analysts covering the stock. Of those, 13 recommend buying, 10 recommend holding, and 2 recommend selling.
The analyst consensus price target for CORT is $68.40, representing a +56.6% upside from the current price of $43.68. Price targets range from a low of $30.00 to a high of $100.00.
